| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.19 | 0.5 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.1 | 0.5 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.11 | 0.5 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.1 | 0.6 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |